Shandong Cancer Hospital And Institute
Clinical trials sponsored by Shandong Cancer Hospital And Institute, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New combo therapy aims to shrink liver tumors in hard-to-treat colorectal cancer Results expected Oct 2026 (estimated)
- New combo therapy aims to outsmart 'Cold' rectal tumors Results expected Nov 2026 (estimated)
- New study aims to decode HER2+ breast cancer for personalized treatment Results expected Dec 2026 (estimated)
- Can a radioactive 'Smart Bomb' target tough tumors? Results expected May 2027 (estimated)
- New radiation method aims to boost tumor fight in sarcoma patients Results expected May 2027 (estimated)
-
Triple threat against pancreatic cancer: radiation, immunotherapy, and chemotherapy combined
Disease control Not yet recruitingThis phase 2 trial tests a new treatment approach for people with locally advanced pancreatic cancer that cannot be removed by surgery. Participants receive targeted radiation therapy followed by a combination of two immunotherapy drugs (ipilimumab N01 and sintilimab) plus standa…
Phase 2 • Sponsor: Shandong Cancer Hospital and Institute • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
AI takes on cancer experts: who makes better treatment plans?
Knowledge-focused Not yet recruitingThis study will compare treatment recommendations made by a large language model (AI) with those made by a team of cancer experts for 180 people with rectal cancer. The AI will analyze de-identified patient information and suggest a treatment plan. The goal is to see how often th…
Sponsor: Shandong Cancer Hospital and Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
New study aims to decode HER2+ breast cancer for personalized treatment
Knowledge-focused Not yet recruitingThis study will enroll over 1,000 women with HER2-positive breast cancer to analyze the molecular characteristics and subtypes of their tumors. Participants will receive standard pre-surgery treatment with trastuzumab, pertuzumab, and chemotherapy. The goal is to identify which s…
Sponsor: Shandong Cancer Hospital and Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC